
UHS Q4 2024 Earnings Report
Key Takeaways
Universal Health Services, Inc. reported Q4 2024 revenue of $4.11 billion, an increase of 11.1% year-over-year. Net income rose to $332.4 million, while adjusted EPS increased to $4.92. Revenue from acute care and behavioral health services grew by 8.7% and 11.1%, respectively. EBITDA net of NCI improved to $620.2 million, reflecting strong operational performance.
Revenue increased 11.1% year-over-year to $4.11 billion.
Net income rose 53.6% to $332.4 million, with adjusted EPS at $4.92.
EBITDA net of NCI reached $620.2 million, up from $476.9 million in Q4 2023.
Acute care and behavioral health revenue grew 8.7% and 11.1%, respectively.
UHS Revenue
UHS EPS
UHS Revenue by Segment
UHS Revenue by Geographic Location
Forward Guidance
UHS expects continued revenue growth in 2025, driven by strong performance in both acute care and behavioral health segments. The company aims to enhance operational efficiencies while managing labor and expense pressures.
Positive Outlook
- Projected 2025 revenue growth of 7.5% to 9.7% over 2024.
- Expected Adjusted EBITDA net of NCI between $2.36 billion and $2.48 billion.
- Continued expansion of behavioral health services.
- Operational efficiencies expected to improve margins.
- Projected EPS-diluted range of $18.45 to $19.95.
Challenges Ahead
- Higher labor costs could impact margins.
- Potential reimbursement pressures from Medicare and Medicaid changes.
- Regulatory risks in key operating regions.
- Increased interest expenses due to debt levels.
- Continued competitive pressures in the healthcare sector.